The targeted drug selpercatinib has been a treatment option for some people with lung cancer or…
Non-small Cell Lung Cancer Indicated for metastatic non-small cell lung cancer (NSCLC) in adults whose tumors…
Trametinib is a kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers…
Dabrafenib is an anti-cancer medication used for the treatment of cancers associated with a mutated version of the…
Osimertinib is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a…
Sotorasib is an anti-cancer medication used to treat non-small-cell lung cancer (NSCLC).It targets a specific mutation,…
Sotorasib is in a class of medications called KRAS inhibitors. It works by blocking the action of…
Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that…
Capmatinib is in a class of medications called kinase inhibitors. It works by blocking the action of…
Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that…
Brigatinib is a targeted cancer drug treatment for non small cell lung cancer (NSCLC). It is also…
Tepotinib is a kinase inhibitor directed against MET, including variants with exon 14 skipping - it…
Lorlatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) in adults that…
Larotrectinib is a treatment for solid cancers that have a neurotrophic tyrosine receptor kinase (NTRK) gene change.…
Alectinib is a type of cancer growth blocker called a tyrosine kinase inhibitor. It works by…
Lorlatinib, sold under the brand name Pholorla100,Lorbrena in the United States, Canada, and Japan, and Lorviqua…